Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Kim S, Matsumoto K, Nakamura T, Higaki J, Ogihara T
Department of Geriatric Medicine, Biomedical Research Center, Osaka University Medical School, Japan.
J Hypertens. 2000 Oct;18(10):1411-20. doi: 10.1097/00004872-200018100-00008.
To investigate the molecular mechanisms of the anti-apoptotic action of hepatocyte growth factor (HGF), a novel angiogenic growth factor that may have a pivotal role in the regulation of endothelial cells, on human aortic endothelial cells.
An index of cell number and death was determined using a water-soluble tetrazolium salt dye assay, DNA fragmentation enzyme-linked immunosorbent assay, and non-confocal fluorescence microscopy of nuclear staining with Hoechst 33258 and propidium iodide. Extracellular-signal-regulated protein kinase (ERK) and the p38 mitogen-activated protein kinase (p38MAPK) were analysed by Western blotting using a phospho-specific antibody.
Treatment of quiescent endothelial cells with HGF resulted in significant dose-dependent increases in cell numbers and decreases in lactate dehydrogenase (LDH) release. Moreover, HGF significantly attenuated endothelial cell death induced by culture in serum-free conditions. We therefore focused on the signal transduction system, and in particular on ERK and p38MAPK. ERK was markedly phosphorylated by HGF. The contribution of ERK to cell growth was supported by the observation that addition of PD98059, a specific inhibitor of MAPK kinase, significantly attenuated the increase in endothelial cell numbers induced by HGF, in a dose-dependent manner. Similarly, PD98059 also attenuated the decrease in LDH release and DNA fragmentation by HGF under serum-free conditions. Interestingly, ERK was re-phosphorylated at 12 h after stimulation. Re-phosphorylation of ERK was the result of induction of endogenous HGF by exogenously added HGF, as addition of neutralizing anti-HGF antibody to the conditioned medium attenuated re-phosphorylation of ERK at 12 h. In contrast, although p38MAPK was also phosphorylated by HGF, SB203580, a specific inhibitor of p38MAPK, failed to change the endothelial cell growth induced by HGF.
We have demonstrated that the anti-apoptotic action of HGF against endothelial cell death was mainly through phosphorylation of ERK on human endothelial cells.
研究肝细胞生长因子(HGF)对人主动脉内皮细胞的抗凋亡作用的分子机制。HGF是一种新型血管生成生长因子,可能在内皮细胞调节中起关键作用。
使用水溶性四氮唑盐染料测定法、DNA片段化酶联免疫吸附测定法以及用Hoechst 33258和碘化丙啶进行核染色的非共聚焦荧光显微镜检查来确定细胞数量和死亡指标。使用磷酸特异性抗体通过蛋白质印迹法分析细胞外信号调节蛋白激酶(ERK)和p38丝裂原活化蛋白激酶(p38MAPK)。
用HGF处理静止的内皮细胞导致细胞数量显著剂量依赖性增加,乳酸脱氢酶(LDH)释放减少。此外,HGF显著减轻了无血清培养诱导的内皮细胞死亡。因此,我们重点研究信号转导系统,特别是ERK和p38MAPK。ERK被HGF显著磷酸化。添加MAPK激酶的特异性抑制剂PD98059显著剂量依赖性地减弱了HGF诱导的内皮细胞数量增加,这一观察结果支持了ERK对细胞生长的作用。同样,PD98059也减弱了无血清条件下HGF诱导的LDH释放减少和DNA片段化。有趣的是,刺激后12小时ERK再次磷酸化。ERK的再次磷酸化是外源性添加的HGF诱导内源性HGF的结果,因为向条件培养基中添加中和抗HGF抗体减弱了12小时时ERK的再次磷酸化。相比之下,尽管p38MAPK也被HGF磷酸化,但p38MAPK的特异性抑制剂SB203580未能改变HGF诱导的内皮细胞生长。
我们已经证明,HGF对内皮细胞死亡的抗凋亡作用主要是通过人内皮细胞上ERK的磷酸化实现的。